Effect of octreotide on 24-hour growth hormone and prolactin secretory patterns in acromegalics

Horm Res. 1991;36(5-6):209-15. doi: 10.1159/000182164.

Abstract

Four adult patients with active acromegaly underwent studies of their 24-hour secretory pattern of hGH and Prl prior to and at the end of 3 months of treatment with the octreotide (somatostatin analog SMS 201-995) 100 micrograms s.c. every 8 h. Blood was withdrawn at 30-min intervals with the aid of a constant withdrawal pump. The best fit cosinor method was used to define the following rhythm parameters: mesor, amplitude, acrophase and periodicity. Prior to treatment, hGH secretion was increased in all patients. The mean 24-hour ranged from 9-47 ng/ml with amplitude 5.2-23 and observed maximal pulse 41-95 ng/ml. Computed rhythms were circadian in 3 patients and ultradian in 1; in 2 patients the acrophases were shifted to daytime. hPrl secretion was altered in 3 of the patients. Two had elevated mean 24-hour of 17.7 and 22.2 ng/ml, while computed rhythms showed semicircadian periodicity in 1 of them and circadian periodicity with a shift of acrophase to daytime in the other. The third patient who had normal hPrl levels, showed ultradian 8-hour periodicity. At the end of treatment there was a marked reduction in hGH secretion in 1 patient and a lesser reduction in the other 3. The rhythm was influenced by the masking effect of the drug, to yield an 8-hour period with acrophases related to injection clock time having equal amplitudes.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH terms

  • Acromegaly / drug therapy*
  • Acromegaly / physiopathology
  • Adult
  • Aged
  • Circadian Rhythm
  • Female
  • Growth Hormone / metabolism
  • Humans
  • Male
  • Middle Aged
  • Octreotide / administration & dosage
  • Octreotide / therapeutic use*
  • Prolactin / metabolism

Substances

  • Prolactin
  • Growth Hormone
  • Octreotide